Current Report Filing (8-k)
December 08 2017 - 1:45PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 6, 2017
MEDICAL
INNOVATION HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Colorado
|
|
000-27211
|
|
84-1469319
|
(State
or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
5805
State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address
of Principal Executive Offices) (Zip Code)
(866)
883-3793
(Registrant’s
telephone number, including area code)
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
SECTION
7 — REGULATION FD DISCLOSURE
Item
7.01 Regulation FD Disclosure
.
Press
Release
The
information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed”
for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that
Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing
under
the Securities Act or the Exchange Act regardless of any general incorporation language
in
such filing.
On
December 6, 2017 Medical Innovation Holdings Inc. issued a press release.
The
text of the press release in its entirety is attached herewith as Exhibit 99.1.
SECTION
9 — FINANCIAL STATEMENTS AND EXHIBITS
ITEM
9.01 Financial Statements and Exhibits.
The
following is a complete list of exhibits filed as part of this Report.
Exhibit
numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Innovation Holdings, Inc.
|
|
|
|
By
|
/s/
Arturo Jake Sanchez
|
|
Name:
|
Arturo
“Jake” Sanchez
|
|
Title:
|
CEO
|
Date:
December 8, 2017